SE428471B - Sett att framstella imidazolderivat - Google Patents

Sett att framstella imidazolderivat

Info

Publication number
SE428471B
SE428471B SE7510595A SE7510595A SE428471B SE 428471 B SE428471 B SE 428471B SE 7510595 A SE7510595 A SE 7510595A SE 7510595 A SE7510595 A SE 7510595A SE 428471 B SE428471 B SE 428471B
Authority
SE
Sweden
Prior art keywords
make
imidazold
derivatives
imidazold derivatives
make imidazold
Prior art date
Application number
SE7510595A
Other languages
English (en)
Swedish (sv)
Other versions
SE7510595L (sv
Inventor
K A M Walker
Original Assignee
Syntex Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syntex Inc filed Critical Syntex Inc
Publication of SE7510595L publication Critical patent/SE7510595L/xx
Publication of SE428471B publication Critical patent/SE428471B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Plural Heterocyclic Compounds (AREA)
SE7510595A 1974-09-23 1975-09-22 Sett att framstella imidazolderivat SE428471B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US50838474A 1974-09-23 1974-09-23
US59362075A 1975-07-07 1975-07-07

Publications (2)

Publication Number Publication Date
SE7510595L SE7510595L (sv) 1976-03-24
SE428471B true SE428471B (sv) 1983-07-04

Family

ID=27056177

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7510595A SE428471B (sv) 1974-09-23 1975-09-22 Sett att framstella imidazolderivat

Country Status (19)

Country Link
JP (1) JPS5910344B2 (no)
AR (1) AR224222A1 (no)
AU (1) AU496881B2 (no)
CA (1) CA1064040A (no)
CH (1) CH623813A5 (no)
DE (1) DE2541833A1 (no)
DK (1) DK155283C (no)
FI (1) FI64583C (no)
FR (1) FR2285126A1 (no)
GB (1) GB1485719A (no)
HK (1) HK8380A (no)
IE (1) IE43267B1 (no)
IL (1) IL47885A (no)
MX (1) MX4832E (no)
MY (1) MY8000270A (no)
NL (1) NL174462C (no)
NO (1) NO144345C (no)
SE (1) SE428471B (no)
YU (3) YU39746B (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA755100B (en) * 1974-09-23 1977-03-30 Syntex Inc 1-(b-(r-thio) phenethyl) imidazoles and derivatives thereof
DE2963796D1 (en) * 1979-01-22 1982-11-11 Syntex Inc Imidazole derivatives, pharmaceutical compositions containing them and their preparation
JPS63156228U (no) * 1987-04-01 1988-10-13
DE3939525A1 (de) * 1989-11-30 1991-06-06 Hoechst Ag Mit mehrfach ungesaettigten resten substituierte aryl-alkyl-azole, verfahren zu ihrer herstellung und ihre verwendung
IT1303672B1 (it) * 1998-07-28 2001-02-23 Nicox Sa Sali nitrati di farmaci attivi nei disordini ossei
CN116063234B (zh) * 2022-12-29 2023-11-24 山东京卫制药有限公司 一种硝酸硫康唑的制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU557755A3 (ru) * 1968-08-19 1977-05-05 Янссен Фармасьютика Н.В. (Фирма) Способ получени производных имидазола
US3658813A (en) * 1970-01-13 1972-04-25 Janssen Pharmaceutica Nv 1-(beta-aryl-beta-(r-oxy)-ethyl)-imidazoles
DE2041771C3 (de) * 1970-08-22 1979-07-26 Bayer Ag, 5090 Leverkusen derivate
SE364275B (no) * 1971-06-17 1974-02-18 Janssen Pharmaceutica Nv
DE2242454A1 (de) * 1972-08-29 1974-03-07 Bayer Ag 1-aethyl-imidazole, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel

Also Published As

Publication number Publication date
AR224222A1 (es) 1981-11-13
CH623813A5 (en) 1981-06-30
NO144345B (no) 1981-05-04
HK8380A (en) 1980-03-14
YU39746B (en) 1985-04-30
DE2541833C2 (no) 1989-09-14
FI752614A (no) 1976-03-24
DK155283C (da) 1989-07-24
CA1064040A (en) 1979-10-09
YU226981A (en) 1982-02-28
MY8000270A (en) 1980-12-31
AU8408175A (en) 1977-02-24
NL174462C (nl) 1984-06-18
AU496881B2 (en) 1978-11-09
GB1485719A (en) 1977-09-14
IL47885A (en) 1979-01-31
YU224475A (en) 1982-02-28
IE43267B1 (en) 1981-01-28
NL7510224A (nl) 1976-03-25
MX4832E (es) 1982-10-26
DK155283B (da) 1989-03-20
JPS5910344B2 (ja) 1984-03-08
DK427075A (da) 1976-03-24
YU227081A (en) 1982-02-28
IL47885A0 (en) 1975-11-25
FI64583B (fi) 1983-08-31
DE2541833A1 (de) 1976-04-01
NL174462B (nl) 1984-01-16
JPS5157828A (en) 1976-05-20
NO753048L (no) 1976-03-24
FR2285126A1 (fr) 1976-04-16
FR2285126B1 (no) 1979-09-14
IE43267L (en) 1976-03-23
NO144345C (no) 1981-08-12
SE7510595L (sv) 1976-03-24
FI64583C (fi) 1983-12-12

Similar Documents

Publication Publication Date Title
SE7512087L (sv) Sett att framstella vattensvellbar polyalkylenoxid
SE432247B (sv) Sett att framstella dihydro-cyklosporin c
SE433222B (sv) Sett att framstella modifierad polysackarid
SE419645B (sv) Sett att framstella 3-amino-indazolkarbonylsyra derivat
SE7606280L (sv) Sett att framstella etrar
SE7506743L (sv) Sett att framstella bispidin- och bispidonderivat
SE430887B (sv) Sett att framstella vissa substituerade fenylguanidiner
SE425244B (sv) Sett att framstella 4-hydroxi-3-kinolin-karboxamidderivat
SE420728B (sv) Sett att framstella piperazinyliminorifamyciner
SE417507B (sv) Sett att framstella 2-arylamino-2-imidazolinderivat
SE420602B (sv) Sett att framstella pyrazin-3-metoxi-2-karboxamidderivat
SE413598B (sv) Sett att framstella 7-amino-delta?723-cefem-derivat
SE425312B (sv) Sett att framstella morfolinderivat
SE425850B (sv) Sett att framstella abietamidderivat.
SE431983B (sv) Sett att framstella 15-etylendioxiprostansyraderivat
SE427655B (sv) Sett att framstella abietamidderivat
SE430156B (sv) Sett att framstella 2-subst-1-(omega-aminoalkoxi)-bensener
SE427930B (sv) Sett att atervinna organotennhalogenider
SE428471B (sv) Sett att framstella imidazolderivat
SE419647B (sv) Sett att framstella tiazolisokinolinderivat
SE7509209L (sv) Sett att framstella nya kinolinderivat
SE7607171L (sv) Sett att framstella indolokinoliziner
SE415252B (sv) Sett att framstella nya oxifenylbutazonderivat
SE7508561L (sv) Sett att framstella alfa-azidobensylpenicillin
SE7508779L (sv) Sett att framstella prostaninsyraderivat

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 7510595-7

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 7510595-7

Format of ref document f/p: F